GeneVax AI
Cambridge, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $55M
Overview
An AI-driven platform company designing novel vaccines and genetic medicines.
Infectious DiseaseOncologyGenetics & Genomics
Technology Platform
An AI/ML platform that analyzes genomic data to predict and design optimal antigens and genetic constructs for vaccines and therapies.
Funding History
1Total raised:$55M
Private Equity$55M
Opportunities
Successful validation of its platform could lead to numerous high-value partnerships and a broad pipeline of assets.
Risk Factors
Platform risk: the core AI models may fail to generate clinically effective candidates, rendering the technology invalidated.
Competitive Landscape
Part of a crowded and highly competitive field of AI-driven drug discovery companies, requiring clear validation of its platform's output.